With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- Human Rights Watch and Amnesty International called for the “immediate and unconditional” release of artists Luis Otero Alcántara and “El Osorbo” May 26, 2022
- Lyon: The return of heating in schools, end of the strike Nov 16, 2022
- JPMorgan to take majority stake in Volkswagen payments platform Sep 8, 2021
- The perpetrator of the massacre in Texas announced his plan on his Facebook account minutes before attacking the elementary school May 25, 2022
- Andrea Casiraghi rebel ? He wears a mask bit classic for the family of Monaco May 25, 2020
- Vocational high school: Many establishments on strike this Thursday to protest against a reform project Nov 17, 2022
- Rennes: Three bodies, including two of women, discovered in a house Nov 23, 2022